Christopher R. Fenimore

Insider Reports History

Entity
Individual
Location
Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York
Signature
/s/**Christopher R. Fenimore
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher R. Fenimore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 14,372 $13.7 M $955.00 Feb 9, 2024 Direct
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 4,269 $4.08 M $955.00 Feb 9, 2024 2022 GRAT
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 1,897 $1.81 M $955.00 Feb 9, 2024 By Trust
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 1,499 $1.43 M $955.00 Feb 9, 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 1,473 $1.41 M $955.00 Feb 9, 2024 2021 GRAT
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 461 $440 K $955.00 Feb 9, 2024 by Trust for Daugh
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Common Stock 460 $439 K $955.00 Feb 9, 2024 by Trust for Son
REGENERON PHARMACEUTICALS, INC. SVP Finance & CFO Non-Qualified Stock Option (right to buy) 0 Jan 23, 2024 Direct

Insider Reports Filed by Christopher R. Fenimore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Feb 9, 2024 6 -4,689,320 4 Feb 12, 2024 SVP Finance & CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 23, 2024 6 -2,402,547 4 Jan 25, 2024 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2024 6 -2,076,548 4 Jan 4, 2024 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 27, 2023 1 -2,097,226 4 Dec 29, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 21, 2023 3 -1,629,502 4 Dec 26, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 12, 2023 1 -2,186,324 4 Dec 14, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2023 5 -1,696,479 4 Dec 12, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Aug 23, 2023 3 -1,582,527 4 Aug 25, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Mar 23, 2023 1 -1,767,782 4 Mar 27, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Feb 3, 2023 3 -1,192,167 4 Feb 7, 2023 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2022 2 0 4 Dec 20, 2022 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 9, 2022 4 -186,060 4 Dec 13, 2022 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Oct 5, 2022 1 -1,381,156 4 Oct 7, 2022 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Oct 3, 2022 1 -2,422,504 4 Oct 5, 2022 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Apr 8, 2022 6 -1,413,652 4 Apr 11, 2022 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Mar 31, 2022 6 -2,250,727 4 Apr 1, 2022 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 11, 2021 1 -179,372 4 Dec 14, 2021 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2021 2 0 4 Dec 10, 2021 SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Aug 20, 2021 1 -5,796,827 4/A Aug 25, 2021 SVP Controller